I started my career at the intersection of machine learning and molecular biology, building models that could learn the hidden logic of proteins — how their shapes define their functions, and how tiny changes in structure can transform biology itself.

Over time, my research evolved from studying proteins to designing small molecules — using generative models and chemical foundation networks to predict lipophilicity, receptor affinity, and stability.
My focus now is on discovering new lipophilic small molecules that can drive ECM remodeling, A₂A receptor modulation, and mTOR regulation — pathways at the core of cellular repair, collagen synthesis, and longevity.

From AI Models to the Skin

While the tools I built were powerful, most of their impact stayed locked inside pharma pipelines.
I kept wondering: What if we could apply the same level of precision to the skin — the body’s most visible organ?

That question became the seed for AEON — a platform that merges AI-driven molecule discovery with advanced dermal delivery systems, like transfersomes and dissolving microneedles.

To me, skincare is no longer about surface-level effects; it’s about engineering biological change at the molecular scale.
Every serum, patch, or capsule I design is an experiment in how intelligence — human and artificial — can collaborate with biology to restore and extend skin function.

Engineering Beauty as a Biological System

At AEON, I’m building what I think of as a living interface between science and skin.
Our actives are generated through machine learning, but they’re grounded in decades of biochemistry and material science.
We don’t just mix ingredients — we model molecular behavior, simulate delivery, and optimize interactions with real biological systems.

It’s a fusion of computation, chemistry, and design — all focused on one measurable outcome: dermal longevity.
When we talk about anti-aging, I don’t think in years — I think in mechanisms: reducing oxidative load, restoring collagen architecture, modulating mTOR.
That’s where true change begins.

Bringing Biotech to the Masses

I believe biotech shouldn’t live in whitepapers or clinical labs — it should live on shelves, in homes, and on skin.
For too long, skincare has been driven by marketing language instead of molecular data.
My goal is to change that — to make biotech beautiful, tangible, and accessible, without diluting its scientific integrity.

I want AEON to be more than a skincare brand.
I want it to be a movement that brings scientific curiosity to the mirror — where each formulation is a small act of biological design, and every user becomes part of a much larger experiment: how we can extend cellular health through intelligent materials.

“I’m not just trying to make better skincare — I’m trying to build the interface between biotechnology and human experience.”